Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Carotid Atherosclerosis, Asymptomatic Carotid Artery Stenosis, Carotid Artery Atheroma
Interventions: 64Cu-25%-CANF-Comb; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • St Louis, Missouri

Conditions: Stroke
Interventions: high frequency rTMS; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Spinal Cord Injury, Stroke, Acquired Brain Injury
Interventions: AMES Therapy; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Stroke
Interventions: Soft exosuit, Gait training without exosuits; Device · Behavioral
Lead sponsor: Lou Awad, PT, DPT, PhD; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Boston, Massachusetts • Charlestown, Massachusetts

Conditions: Stroke, Chronic Conditions
Interventions: Self- management program, Standard care; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Stroke
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Hypertension, Diabetes Mellitus, Stroke, Myocardial Ischemia, Heart Failure, Asthma
Interventions: Medication Management report, Care manager email notices; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hypoxic-ischemic Encephalopathy, Neonatal Encephalopathy, Birth Asphyxia
Interventions: Erythropoietin, Normal saline; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 30 Minutes to 24 Hours
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 7
States / cities: Little Rock, Arkansas • Palo Alto, California • San Francisco, California + 4 more

Conditions: Stroke
Interventions: Visumotor Upper Extremity Training, Anodal/Sham tDCS; Other
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: Desmoteplase, Placebo; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 81
States / cities: Phoenix, Arizona • Castro Valley, California • La Jolla, California + 66 more

Conditions: Stroke, Systemic Embolism, VTEt and VTEp
Interventions: Not listed
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Headache, Meningitis, Subarachnoid Hemorrhage
Interventions: Ultrasound; Device
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Disease, Cerebrovascular Accident, Coronary Heart Disease
Interventions: Atorvastatin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 8,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 181
States / cities: Alabaster, Alabama • Birmingham, Alabama • Hoover, Alabama + 129 more

Conditions: Intracerebral Hemorrhage
Interventions: Frequency of neurochecks; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 100 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Spinal Cord Injuries, Stroke, Acquired Brain Injury, Movement Disorders
Interventions: Kinesthetic Awareness Training, Provision of KAT-assisted physical or occupational therapy; Behavioral
Lead sponsor: PantherTec; Industry
Eligibility: 16 Years to 70 Years
Enrollment: 20 participants
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Multiple Sclerosis, Stroke
Interventions: Movement to Music, Adapted Yoga; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 65 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke
Interventions: PAS true, PAS sham; Behavioral
Lead sponsor: Burke Medical Research Institute; Other
Eligibility: 19 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Subdural Hematoma
Interventions: NeoCast Embolic System, Onyx LES, an FDA-Approved Commercial Liquid Embolic; Device
Lead sponsor: Arsenal Medical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: New Haven, Connecticut • Seattle, Washington

Conditions: Rehabilitation, Recovery of Function, Stroke
Interventions: Duck Duck Punch Play, Commercially Available Game Play; Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 90 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Alzheimer's Disease, Dementia, Dementia, Vascular, Caregivers, Veterans
Interventions: Counseling (C), Care Consultation (CC); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Chronic Stroke
Interventions: Biophoton Energizing Brain and Whole Body; Device
Lead sponsor: First Institute of All Medicines; Other
Eligibility: 18 Years to 80 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Butler, Pennsylvania

Conditions: Aneurysm, Aneurysm, Intracranial
Interventions: Surpass Elite with Guardian Flow Diverter System; Device
Lead sponsor: Stryker Neurovascular; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 20
States / cities: Tucson, Arizona • Davis, California • Los Angeles, California + 17 more

Conditions: Ischemic Stroke
Interventions: PF-03049423, Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 32
States / cities: Birmingham, Alabama • Deerfield Beach, Florida • Fort Lauderdale, Florida + 12 more

Conditions: Atrial Fibrillation
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Vitamin K antagonist (VKA); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 1,504 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 66
States / cities: Mobile, Alabama • Scottsdale, Arizona • East Palo Alto, California + 58 more

Search by objective public record fields.

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Non-invasive Brain Stimulation (NIBS) and Dual-task Walking After Stroke

Proprioception Testing in Persons With Sensorimotor Impairment

Robotic Exosuit Augmented Locomotion (REAL)

Feasibility of a Stroke Specific Self-management Program

Effect of Transcranial Magnetic Stimulation on Recovery of Upper Limb Among Stroke Survivors

Clinical Decision Support for Medication Management and Adherence

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

Using Transcranial Direct Current Stimulation (tDCS) to Enhance the Benefit of Movement Training in Stoke Patients

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture?

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Short-term And Longer-term Cognitive Impact Of Neurochecks

Motion Sensor and Feedback System Efficacy to Refine Movements After Injury

Lakeshore Examination of Activity and Disability Exercise Response Study

Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke

MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

Functional Viability Duck Duck Punch

Optimizing Dementia Care

Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators

Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion